Stock exchanges & markets

Overview Watchlists

Idorsia partners with Jamjoom Pharma to commercialize insomnia drug Quviviq in Saudi Arabia, Levant

27. Jul 2026

(AWP Alliance News) - Idorsia entered an exclusive partnership with Jamjoom Pharma to commercialize insomnia drug QUVIVIQ (daridorexant) in Saudi Arabia and the Levant region. Jamjoom will hold the marketing authorization in Saudi Arabia, leading regulatory, distribution, promotion, and commercialization across the territories.

Idorsia will supply finished product under the deal. The agreement includes an upfront payment, potential additional milestones, and royalties on net sales.

https://www.globenewswire.com/NewsRoom/ReleaseNg/402468689

Disclaimer: This news brief was created using generative artificial intelligence. Idorsia Ltd. published the original content used to generate this news brief via GlobeNewswire on July 27, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • ETF Compass

    Stock exchanges & markets

    ETFs are becoming increasingly popular. Our ETF Compass helps you maintain an overview. Filter by criteria such as asset class, region, rating, return or costs. 

    Try the ETF Compass now

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now